Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global therapeutic drug monitoring market size was valued at USD 2.2 billion in 2022, driven by the emphasis on evaluating a drugs’ efficacy in a patient and precision medicine across the globe. The market is expected to grow at a CAGR of 9.1% during the forecast period of 2024-2032, with the values likely to rise from USD 2.4 billion in 2024 to USD 4.8 billion by 2032.
Therapeutic drug monitoring is the periodic measurement of several drugs in the bloodstream. It is an evaluation to ensure that a patient is adhering to the prescribed dosage. It is also used to gauge the effectiveness of the medications.
Therapeutic drug monitoring is used to optimize the dosages for people who are taking certain medicines, which can be hard to dose due to potential side effects. Such medicines may range from antibiotics, heart drugs, anti-seizure drugs, and drugs to treat autoimmune diseases. It is also known as medicine levels blood test or therapeutic drug levels test.
Therapeutic drug monitoring plays a critical role in clinical practice. Monitoring drug levels in individual patients allows for patient-specific dose optimisation. Therefore, there has been a notable upswing in the therapeutic drug monitoring market demand, particularly with precision medicine gaining prominence in today’s healthcare system.
Conventional therapeutic drug monitoring techniques are time-consuming and labour-intensive. They require large sample volumes, along with a substantial number of organic solvents. In some cases, samples must be sent to central laboratories for analysis as well, potentially causing a delay in getting the required results. In this regard, Raman spectroscopy has emerged as a promising technique that offers label-free and non-invasive characteristics that also facilitate smooth, rapid, and precise analysis.
Furthermore, UCL researchers have also developed a new drug-monitoring tool called ChromaDose that calculates the efficacy of cancer medicine in a patient’s bloodstream. It is aimed at reducing heart issues and other side effects experienced by kids receiving chemotherapy. This point-of-care tool can be made available in hospitals by 2025. In addition, there has been ongoing research on dual-colour bioluminescent sensor proteins for therapeutic drug monitoring of antitumor antibodies. As research and development continue to progress, therapeutic drug monitoring market value will increase in the forecast period.
Market Breakup by Product Type
Market Breakup by Type
Market Breakup by Drug Class
Market Breakup by End User
Market Breakup by Region
With the prominence of precision medicine, researchers have turned towards therapeutic drug monitoring for treating diseases where accurate measurement of drugs plays a vital role in the treatment. For instance, in diseases like inflammatory bowel disease and paediatric cystic fibrosis treatment, therapeutic drug monitoring is being used to enhance treatment outcomes. This indicates the certainty of therapeutic drug monitoring market growth in upcoming years.
Considering the growing population, developing infrastructure, and increased technical advancements in the Asia Pacific region, the market for therapeutic drug monitoring is expected to observe a steep growth. Increased awareness regarding diagnostics is another factor fuelling the growth, in contrast to the historical period, when the United States led the therapeutic drug monitoring market share. This can be attributed to the presence of major healthcare giants in the area, committed to work on new innovations, envisioned at improving patient treatment and overall experience.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Type |
|
Breakup by Drug Class |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 2.2 billion in 2023, driven by the emphasis on analysing the effectiveness of a particular in a patient’s bloodstream.
The market is anticipated to grow at a CAGR of 9.1% during the forecast period of 2024-2032, likely to reach a market value of USD by 4.8 billion in 2032.
The evolution from time-consuming and labour-intensive methods to rapid and non-invasive drug monitoring devices has been a key factor for market growth. The prevalence of precision medicine is another critical aspect.
New methods and tools like Raman spectroscopy and ChromaDose are being used to offer accurate, rapid, and non-invasive analysis for patients. North America has led the market share in historic period, which currently seems to shift towards the Asia Pacific region.
Immunoassays and proteomic technologies are different types of therapeutic drug monitoring.
Product types can be divided into consumables and devices like immunoassay analysers, chromatography and MS detectors, and clinical chemistry analysers, among others.
Drug classes included are antiepileptic, antiarrhythmic, immunosuppressants, antibiotic drugs, bronchodilator drugs, and psychoactive drugs, among others.
Hospitals, commercial and private laboratories, among others are the major end users.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Abbott, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers AG, Bio-Rad Laboratories, Biomérieux Sa, Theradiag, Grifols S.A., Exagen Inc., Ark Diagnostics, Inc., R-Biopharm A, Apdia Group, Biotez Berlin Buch GmbH, Eagle Biosciences, Inc., and Danaher Corporation.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share